Indication

Upper respiratory infection

An upper respiratory infection is an acute infectious process involving the mucosal surfaces of the upper respiratory tract, including the nasal passages, paranasal sinuses, pharynx, and larynx. Read more about Upper respiratory infection

95 drugs 49 manufacturers

Advertisement

Drugs that treat it

Common Upper respiratory infection therapies.

Showing 82–90 of 95 drugs

AMOXICILLIN

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+28
ENOVACHEM MANUF

CEFACLOR

BETA-LACTAMS·ACUTE BACTERIAL OTITIS MEDIA·+9
AZORIAN PHARMA,

AMOXICILLIN

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+28
USANTIBIOTICS,

AMOXICILLIN

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+28
PD-RX PHARM
Filter & compare in the drug finder →Opens the drug finder with Upper respiratory infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Upper respiratory infection.

An upper respiratory infection is an acute infectious process involving the mucosal surfaces of the upper respiratory tract, including the nasal passages, paranasal sinuses, pharynx, and larynx.

Predominantly caused by viral pathogens such as rhinoviruses, coronaviruses, and adenoviruses—though occasionally caused by bacterial pathogens—it affects both pediatric and adult populations.

Pathophysiologically, pathogen entry and replication trigger local mucosal inflammation, vasodilation, and increased secretions.

This inflammatory cascade manifests clinically with symptoms such as rhinorrhea, nasal congestion, sneezing, sore throat, cough, malaise, and low-grade fever.

Personalize your experience

Follow Upper respiratory infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it